… in patients who have good performance status … to patients who are elderly or with poor
performance status. An important randomized study in elderly NSCLC patients done by the Elderly …

… Increasing interest in designing chemotherapy suitable for use in the elderly and in poor
performance status (PS) patients has led to clinical trials in advanced non-small cell lung cancer …

… patients. However, most clinical trials on ICIs conducted so far have either excluded patients
with poor performance status (… only a minor proportion of elderly patients despite the lack of …

… in patients who are elderly or have poor performance status is … unique cohort of patients is
< 6 months, and most patients are only … survival in elderly or poor performance status patients. …

… Nonetheless, the results of the current trial, coupled with earlier results from the RTOG, indicate
that … is warranted in elderly and/or poor performance status patients with this malignancy. …

… the first-line treatment of elderly and performance status (PS) 2 patients with advanced non-…
Our results help clarify important differences between elderly and PS 2 patients and provide …

… The management of glioblastoma multiforme (GBM) in elderly patients with poor performance
status is not well established. A trial evaluating the efficacy and safety of temozolomide …

… and younger patients derived similar benefit from treatment … 3 trial designed specifically for
elderly patients, single-agent … treatment for elderly and poor performance status patients, we …

… comorbidities and performance status, on short-term outcomes in the very elderly is largely
… in critically ill patients ≥80 years old, emphasizing performance status and comorbidities, …

… , consequently, our results could be transferred to similar patients in clinical practice. Our
results enforce the role of CGA in elderly and/or low-PS lung cancer patients and we strongly …